|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Alterations in mitochondrial function are likely cause of imatinib-ind...
September 01, 2006
Dexedrine.(Medication Safety in brief)
September 01, 2006
Arcoxia.(Medication Safety in brief)
September 01, 2006
Sitagliptin: the first dipeptidyl peptidase IV inhibitor for the treat...
September 01, 2006
Management of epoetin alpha use in the intensive care unit: a drug use...
September 01, 2006
A drug use evaluation of amphotericin B lipid complex injection follow...
September 01, 2006
Atorvastatin fails to demonstrate significant benefit in treatment of ...
September 01, 2006
Elevated atorvastatin dosage reduces rate of cardiovascular events in ...
September 01, 2006
Raloxifene fares as well as tamoxifen in 2 related comparison studies....
September 01, 2006
Raloxifene benefits in breast cancer, increases risk of fatal stroke.(...
September 01, 2006
New data emerge on the relationship between diabetic, pre-diabetic con...
September 01, 2006
Moxifloxacin QD similar to piperacillin-tazobactam and amoxicillin-cla...
September 01, 2006
FDA takes steps to automate drug registration; Plan B OTC availability...
September 01, 2006
Hypertension and stroke.(Drug Watch: A HEADS-UP PHARMACEUTICALS IN LAT...
September 01, 2006
From employers to payers to plans to patients: how to improve treatmen...
September 01, 2006
Ultram[R]er: (tramadol HCl) extended-release tablets: an oral once-dai...
September 01, 2006
Plavix: clopidogrel tablets.(New Indications)
September 01, 2006
Febuxostat (Tap).(Approvable designations)
September 01, 2006
Kiacta.(Approvable designations)
September 01, 2006
Arxxant.(Approvable designations)
September 01, 2006
Totect.(Approvable designations)
September 01, 2006
Thelin.(Priority review)
September 01, 2006
Velcade.(Priority review)
September 01, 2006
Nexavar.(Fast-track designations)
September 01, 2006
Recombinant human C1 inhibitor (rhC1INH, Pharming).(Fast-track designa...
September 01, 2006
Dacogen.(Orphan drug designations)
September 01, 2006
Sparlon.(Nonapprovable designations)
September 01, 2006
Famvir: famciclovir tablets.(New indications)
September 01, 2006
Duetact: pioglitazone and glimepiride tablets.(New formulations)
September 01, 2006
First-time generic approvals.(FDA Drug Approvals)
September 01, 2006
Symbicort.(FDA actions in brief)
September 01, 2006
Keppra.(FDA actions in brief)
September 01, 2006
Plan B.(FDA actions in brief)
September 01, 2006
Oncaspar.(FDA actions in brief)
September 01, 2006
Xolegel.(FDA actions in brief)
September 01, 2006
Humira.(FDA actions in brief)
September 01, 2006
Meta-analysis: anticholinergics reduce COPD exacerbations more effecti...
September 01, 2006
|